Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pin Zhang

5PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Dec 24, 2025

Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis.

Xiaoyan Qian, Xi Chen, Min Xiao

|Jul 21, 2025

Pathologic complete response after neoadjuvant chemotherapy for HER-2 negative breast cancer with HRR mutation.

Xi Chen, Lei Ji, Ying Fan

|Jun 26, 2024

Low-dose pegylated recombinant human granulocyte-colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open-label, randomized, non-inferiority trial.

Sheng Yang, Shan-Shan Chen, Chang-Gong Zhang

|Jun 20, 2023

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial.

Junning Cao, Hongqian Guo, Dongmei Ji

|Apr 11, 2022

Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysis.

Meng Xiu, Pin Zhang, Xiang Wang

Pageof 1

Frequent Collaborators

2 joint publications

Fei Ma

2 joint publications

Xi Chen

1 joint publications

Meng Xiu

1 joint publications

Qiao Li

1 joint publications

Jiayu Wang

1 joint publications

Lin Dong

1 joint publications

Peng Yuan

1 joint publications

Binghe Xu

1 joint publications

Binghe Xu

1 joint publications

Xiaoyan Qian

Frequent Collaborators

2 joint publications

Fei Ma

2 joint publications

Xi Chen

1 joint publications

Meng Xiu

1 joint publications

Qiao Li

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Published on : May 09, 2019

See more related videos

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Published on : May 09, 2019

See more related videos